The role of vitamin K in vascular calcification of patients with chronic kidney disease

References

• Block G, Raggi P, Bellasi A, Kooienga L, Spiegel D. Mortality effect of coronary calcification and phosphate binder choice in incident hemodialysis patients. Kidney Int. 2007;71(5):438–41.10.1038/sj.ki.5002059
   PubMed Web of Science ®Google Scholar
• Schurgers LJ, Teunissen KJ, Knapen MH, Kwaijtaal M, van Diest R, Appels A, et al. Novel conformation-specific antibodies against matrix β-carboxyglutamic acid (Gla) protein: undercarboxylated matrix Gla protein as marker for vascular calcification. Arterioscler Thromb Vasc Biol. 2005;25(8):1629–33.10.1161/01.ATV.0000173313.46222.43
   PubMed Web of Science ®Google Scholar
• Schurgers L, Spronk H, Skepper J, Hackeng T, Shanahan C, Vermeer C, et al. Post-translational modifications regulate matrix Gla protein function: importance for inhibition of vascular smooth muscle cell calcification. J Thromb Haemost. 2007;5(12):2503–11.10.1111/jth.2007.5.issue-12
   PubMed Web of Science ®Google Scholar
• Krueger T, Westenfeld R, Schurgers L, Brandenburg V. Coagulation meets calcification: the vitamin K system. Int J Artif Organs. 2009;32(2):67–74.
   PubMed Web of Science ®Google Scholar
• Zhang YT, Tang ZY. Research progress of warfarin-associated vascular calcification and its possible therapy. J Cardiovasc Pharmacol. 2014;63(1):76–82.10.1097/FJC.0000000000000008
   PubMed Web of Science ®Google Scholar
• Budoff MJ, Rader DJ, Reilly MP, Mohler ER, Lash J, Yang W, et al. Relationship of estimated GFR and coronary artery calcification in the CRIC (chronic renal insufficiency cohort) study. Am J Kidney Dis. 2011;58(4):519–26.10.1053/j.ajkd.2011.04.024
   PubMed Web of Science ®Google Scholar
• Schurgers LJ, Cranenburg EC, Vermeer C. Matrix Gla-protein: the calcification inhibitor in need of vitamin K. Thromb Haemost. 2008;100(4):593–603.
   PubMed Web of Science ®Google Scholar
• McCabe KM, Booth SL, Fu X, Shobeiri N, Pang JJ, Adams MA, et al. Dietary vitamin K and therapeutic warfarin alter the susceptibility to vascular calcification in experimental chronic kidney disease. Kidney Int. 2013;83(5):835–44.10.1038/ki.2012.477
   PubMed Web of Science ®Google Scholar
• Liu S, Gupta A, Quarles LD. Emerging role of fibroblast growth factor 23 in a bone-kidney axis regulating systemic phosphate homeostasis and extracellular matrix mineralization. Curr Opin Nephrol Hypertension. 2007;16(4):329–35.10.1097/MNH.0b013e3281ca6ffd
   PubMed Web of Science ®Google Scholar
• Canalejo R, Canalejo A, Martinez-Moreno JM, Rodriguez-Ortiz ME, Estepa JC, Mendoza FJ, et al. FGF23 fails to inhibit uremic parathyroid glands. J Am Soc Nephrol. 2010;21(7):1125–35.10.1681/ASN.2009040427
   PubMed Web of Science ®Google Scholar
• Brancaccio D, Biondi ML, Gallieni M, Turri O, Galassi A, Cecchini F, et al. Matrix GLA protein gene polymorphisms: clinical correlates and cardiovascular mortality in chronic kidney disease patients. Am J Nephrol. 2005;25(6):548–52.10.1159/000088809
   PubMed Web of Science ®Google Scholar
• Fusaro M, Crepaldi G, Maggi S, Galli F, D’Angelo A, Calò L, et al. Vitamin K, bone fractures, and vascular calcifications in chronic kidney disease: an important but poorly studied relationship. J Endocrinol Invest. 2011;34(4):317–23.10.1007/BF03347093
   PubMed Web of Science ®Google Scholar
• Schurgers L, Dissel P, Spronk H, Soute B, Dhore C, Cleutjens J, et al. Role of vitamin K and vitamin K-dependent proteins in vascular calcification. Z Kardiol. 2001;90(suppl 3):57–63.
   PubMedGoogle Scholar
• Schurgers LJ, Spronk HM, Soute BA, Schiffers PM, DeMey JG, Vermeer C. Regression of warfarin-induced medial elastocalcinosis by high intake of vitamin K in rats. Blood. 2007;109(7):2823–31.
   PubMed Web of Science ®Google Scholar
• Proudfoot D, Shanahan CM. Molecular mechanisms mediating vascular calcification: role of matrix Gla protein. Nephrology 2006;11(5):455–61.10.1111/nep.2006.11.issue-5
   PubMed Web of Science ®Google Scholar
• Kaesler N, Magdeleyns E, Herfs M, Schettgen T, Brandenburg V, Fliser D, et al. Impaired vitamin K recycling in uremia is rescued by vitamin K supplementation. Kidney Int. 2014;86(2):286–93.10.1038/ki.2013.530
   PubMed Web of Science ®Google Scholar
• Neogi T, Booth SL, Zhang YQ, Jacques PF, Terkeltaub R, Aliabadi P, et al. Low vitamin K status is associated with osteoarthritis in the hand and knee. Arthritis Rheum. 2006;54(4):1255–61.10.1002/(ISSN)1529-0131
   PubMed Web of Science ®Google Scholar
• Cranenburg EC, Schurgers LJ, Uiterwijk HH, Beulens JW, Dalmeijer GW, Westerhuis R, et al. Vitamin K intake and status are low in hemodialysis patients. Kidney Int. 2012;82(5):605–10.10.1038/ki.2012.191
   PubMed Web of Science ®Google Scholar
• Shea MK, Holden RM. Vitamin K status and vascular calcification: evidence from observational and clinical studies. Adv Nutr. 2012;3(2):158–65.10.3945/an.111.001644
   PubMed Web of Science ®Google Scholar
• Cheung CL, Sahni S, Cheung BM, Sing CW, Wong IC. Vitamin K intake and mortality in people with chronic kidney disease from NHANES III. Clin Nutr. 2015;34(2):235–40.10.1016/j.clnu.2014.03.011
   PubMed Web of Science ®Google Scholar
• Schurgers LJ, Barreto DV, Barreto FC, Liabeuf S, Renard C, Magdeleyns EJ, et al. The circulating inactive form of matrix Gla protein is a surrogate marker for vascular calcification in chronic kidney disease: a preliminary report. Clin J Am Soc Nephrol. 2010;5(4):568–75.10.2215/CJN.07081009
   PubMed Web of Science ®Google Scholar
• McCabe KM, Adams MA, Holden RM. Vitamin K status in chronic kidney disease. Nutrients. 2013;5(11):4390–8.10.3390/nu5114390
   PubMed Web of Science ®Google Scholar
• Price PA, Faus SA, Williamson MK. Warfarin causes rapid calcification of the elastic lamellae in rat arteries and heart valves. Arterioscler Thromb Vasc Biol. 1998;18(9):1400–7.10.1161/01.ATV.18.9.1400
   PubMed Web of Science ®Google Scholar
• Susantitaphong P, Jaber BL. Potential interaction between sevelamer and fat-soluble vitamins: a hypothesis. Am J Kidney Dis. 2012;59(2):165–7.10.1053/j.ajkd.2011.12.001
   PubMed Web of Science ®Google Scholar
• Price PA, Faus SA, Williamson MK. Warfarin-induced artery calcification is accelerated by growth and vitamin D. Arterioscler Thromb Vasc Biol. 2000;20(2):317–27.10.1161/01.ATV.20.2.317
   PubMed Web of Science ®Google Scholar
• Krueger T, Westenfeld R, Ketteler M, Schurgers LJ, Floege J. Vitamin K deficiency in CKD patients: a modifiable risk factor for vascular calcification? Kidney Int. 2009;76(1):18–22.10.1038/ki.2009.126
   PubMed Web of Science ®Google Scholar
• Hackeng TM, Rosing J, Spronk HM, Vermeer C. Total chemical synthesis of human matrix Gla protein. Protein Sci. 2001;10(4):864–70.10.1110/ps.44701
   PubMed Web of Science ®Google Scholar
• Zebboudj AF, Imura M, Bostrom K. Matrix GLA protein, a regulatory protein for bone morphogenetic protein-2. J Biol Chem. 2002;277(6):4388–94.10.1074/jbc.M109683200
   PubMed Web of Science ®Google Scholar
• Schlieper G, Westenfeld R, Kruger T, Cranenburg EC, Magdeleyns EJ, Brandenburg VM, et al. Circulating nonphosphorylated carboxylated matrix Gla protein predicts survival in ESRD. J Am Soc Nephrol. 2011;22(2):387–95.10.1681/ASN.2010040339
   PubMed Web of Science ®Google Scholar
• Cranenburg EC, Vermeer C, Koos R, Boumans ML, Hackeng TM, Bouwman FG, et al. The circulating inactive form of matrix Gla protein (ucMGP) as a biomarker for cardiovascular calcification. J Vasc Res. 2008;45(5):427–36.10.1159/000124863
   PubMed Web of Science ®Google Scholar
• Cranenburg EC, Koos R, Schurgers LJ, Magdeleyns EJ, Schoonbrood TH, Landewé RB, et al. Characterisation and potential diagnostic value of circulating matrix Gla protein (MGP) species. Thromb Haemosts. 2010;104(4):811–22.
   PubMed Web of Science ®Google Scholar
• Geleijnse JM, Vermeer C, Grobbee DE, Schurgers LJ, Knapen MH, Van Der Meer IM, et al. Dietary intake of menaquinone is associated with a reduced risk of coronary heart disease: the Rotterdam study. J Nutrition. 2004;134(11):3100–5.
   PubMed Web of Science ®Google Scholar
• Westenfeld R, Krueger T, Schlieper G, Cranenburg E, Magdeleyns EJ, Heidenreich S, et al. Effect of vitamin K2 supplementation on functional vitamin k deficiency in hemodialysis patients: a randomized trial. Am J Kidney Dis. 2012;59(2):186–95.10.1053/j.ajkd.2011.10.041
   PubMed Web of Science ®Google Scholar
• Caluwe R, Vandecasteele S, Van Vlem B, Vermeer C, De Vriese AS. Vitamin K2 supplementation in haemodialysis patients: a randomized dose-finding study. Nephrol Dial Transplant. 2014;29(7):1385–90.10.1093/ndt/gft464
   PubMed Web of Science ®Google Scholar
• Krueger T, Schlieper G, Schurgers L, Cornelis T, Cozzolino M, Jacobi J, Jadoul M, et al. Vitamin K1 to slow vascular calcification in haemodialysis patients (VitaVasK trial): a rationale and study protocol. Nephrol Dial Transplant. 2014;29(9):1633–8.10.1093/ndt/gft459
   PubMed Web of Science ®Google Scholar